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Abstract
Extraintestinal pathogenic Escherichia coli (ExPEC) are of significant health concern. The emergence of drug resistant E. coli
with high virulence potential is alarming. Lack of sufficient data on transmission dynamics, virulence spectrum and
antimicrobial resistance of certain pathogens such as the uropathogenic E. coli (UPEC) from countries with high infection
burden, such as India, hinders the infection control and management efforts. In this study, we extensively genotyped and
phenotyped a collection of 150 UPEC obtained from patients belonging to a semi-urban, industrialized setting near Pune,
India. The isolates representing different clinical categories were analyzed in comparison with 50 commensal E. coli isolates
f r o mI n d i aa sw e l la s5 0E x P E Cs t r a i n sf r o mG e r m a n y .V i r ulent strains were identified based on hemolysis,
haemagglutination, cell surface hydrophobicity, serum bactericidal activity as well as with the help of O serotyping. We
generated antimicrobial resistance profiles for all the clinical isolates and carried out phylogenetic analysis based on
repetitive extragenic palindromic (rep)-PCR. E. coli from urinary tract infection cases expressed higher percentages of type I
(45%) and P fimbriae (40%) when compared to fecal isolates (25% and 8% respectively). Hemolytic group comprised of 60%
of UPEC and only 2% of E. coli from feces. Additionally, we found that serum resistance and cell surface hydrophobicity were
not significantly (p=0.16/p=0.51) associated with UPEC from clinical cases. Moreover, clinical isolates exhibited highest
resistance against amoxicillin (67.3%) and least against nitrofurantoin (57.3%). We also observed that 31.3% of UPEC were
extended-spectrum beta-lactamase (ESBL) producers belonging to serotype O25, of which four were also positive for O25b
subgroup that is linked to B2-O25b-ST131-CTX-M-15 virulent/multiresistant type. Furthermore, isolates from India and
Germany (as well as global sources) were found to be genetically distinct with no evidence to espouse expansion of E. coli
from India to the west or vice-versa.
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Introduction
Urinary tract infections (UTI) are the second most common
human infections and are mainly caused by uropathogenic E. coli.
The severity of UTI depends both on the virulence of the bacteria
and the susceptibility of the host [1]. UPEC harbor numerous
virulence factors including alpha-hemolysin, cytotoxic necrotizing
factor, adhesins and iron acquisition systems. These factors
support their ability to adhere to uroepethelial cells, help resist
the bactericidal effect of serum and augment cell surface
hydrophobicity thereby leading ultimately to tissue damage
[2,3,4,5].
Adherence to the urinary tract mucosa might protect bacteria
from urinary lavage and in turn augment their ability to survive
and invade renal tissues [6]. Specific adhesion is mediated by
certain adhesins which can be differentiated based on their
receptor binding specificity.
P fimbriae that are encoded by the E. coli pap (pyelonephritis-
associated pilus) operon are the most important mannose-resistant
adhesins, although they are expressed by only a limited number of
E. coli serotypes. The most rampant P-fimbriated serotypes of the
UPEC strains revealed one of the six O groups O1, O2, O4, O6,
O7, and O18 [6,7,8].
Hemolysin production is another important virulence property
of UPEC. Hemolysins inflict direct cytotoxic effects on renal
epithelium resulting in scaring. Alpha-hemolysin is described to be
a lethal factor with dermonecrotic effects and is antigenic in
nature. Also, hemolysins are toxic to a series of host tissues and
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The frequency of isolation of hemolytic E. coli significantly
associates with the severity of the infection [7,8].
The importance of cell surface hydrophobicity as a virulence
attribute (that facilitates bacterial adherence to mammalian cells) is
known for nearly a century now, thanks to the pioneering studies
of Mudd and Mudd [4]. It is an important factor helping E. coli to
adhere to various surfaces for colonization. Bacteria are lysed by
normal serum due to the activity of the complement system. The
alternate pathway of complement activation is potentially
important than the classical pathway. Bacterial resistance to
killing by serum results from individual or combined effects of
capsular polysaccharides, lipopolysaccharides and surface proteins
[4]. Given this generic virulence ‘arsenal’ of UPEC, strains from
different geographical regions pose different disease severity and
should be genetically different.
To screen for the above mentioned virulence attributes and to
find the most predominant serotypes among UPEC in the western
Indian region, we analyzed 150 human clinical isolates. We
intended to classify them epidemiologically into different serotypes
and to obtain virulence marker profiles of UPEC (which have
different frequencies in different disease conditions ranging from
asymptomatic bacteriuria to chronic pyelonephritis). In addition,
increasing antimicrobial resistance in bacterial pathogens is of
major concern as it can vary according to geographical and
regional situations [9,10,11,12]. It is very relevant to ensure the
appropriate therapy based on full knowledge of the organisms that
cause UTI and their antibiotic susceptibility profiles. Therefore, it
is necessary to do bacteriological testing also with reference to
extended-spectrum beta-lactamase (ESBL) producers with resis-
tance to beta-lactam antibiotics, including third generation
cephalosporins such as cefotaxime, ceftriaxone and ceftazidime.
Not much information on ESBL producing organisms causing
UTI is available from India.
The present work was essentially carried out as an important
precursor of a larger study aimed at understanding the
transmission dynamics, population genetic structure and virulence
mechanisms of UPEC from India. Herein, we present a much
needed snapshot comprising of the virulence characteristics and
antimicrobial resistance patterns of the available UPEC strains
from western India representing the clinical conditions such as
symptomatic UTI, bacteriuria, pyelonephritis, cystitis, prostatitis,
septicemia and pyrexia of unknown origin (PUO). We sought to
define the clinical correlates of different virulence factors and their
association with various biological and life-style related factors of
the host. In addition, we used rep-PCR based DNA profiling to
know the genetic affinities of our isolates and to explore if this
simple PCR based genetic analysis helps in understanding their
spread patterns indicative of their diverse or clonal relationships.
Also, we attempted to use this technique to know whether the
bacterial isolates have any geographic inclination and how similar
or different they are when compared to some of the well
characterized isolates from western countries such as Germany.
Materials and Methods
Ethics statement
Written informed consents were obtained from all patients and
healthy controls for the use of their strains which were cultured as
part of compulsory diagnostic screening. Study protocols were
approved by the institutional ethics committee of Dr. D. Y. Patil
Medical College, Pune and by the Institutional Biosafety
Committee of the School of Life Sciences of the University of
Hyderabad, India.
Study population and strains
One hundred and fifty E. coli isolates were obtained from urine
samples of human patients in cell counts of 10
5/ml. Fifty fecal E.
coli isolates (that were used as controls), were isolated from the
feces of healthy individuals who had reported for routine health
checkup between January 2009–March 2010 at Dr. D. Y. Patil
Medical College and Hospital, Pimpri, Pune, India. Patient
background and provisional diagnosis of the infection were
obtained from hospital records (Table S1). Identification of isolates
was done using standard microbiological techniques [13,14,15].
All strains were stored on 15% glycerol-supplemented Luria-
Bertani medium at 280uC.
DNA samples
DNA samples of fifty ExPEC isolates from Germany and from
global sources [16] were obtained; these represented various
animal and human specimens, including 17 UPEC and archetyp-
ical newborn meningitis strain RS218 from humans, two UPEC
from dogs and 31 avian pathogenic E. coli (APEC) from different
birds. These strains were used for repetitive extragenic palin-
dromic (rep) PCR together with the aforementioned human
clinical isolates.
Antimicrobial susceptibility test
The antimicrobial susceptibility testing was carried out on
Mueller Hinton agar by disc diffusion method using the following
antimicrobial substances [17]: amoxicillin (10 mg), ceftazidime
(30 mg), ciprofloxacin (10 mg), co-trimoxazole (25 mg), gentamicin
(10 mg), nitrofurantoin (300 mg), nalidixic acid (30 mg), and
tetracycline (30 mg). Multi-drug resistant (MDR) strains were
defined as those which showed resistance to three or more
antimicrobial substances. Extended-spectrum beta-lactamase
(ESBL) production was detected by the double-disk synergy
(DDS) test as recommended by the Clinical and Laboratory
Standards Institute (CLSI, 2006). Its presence was assayed using
the antibiotic disks comprising of ceftazidime and ceftazidime/
clavulanic acid (30/10 mg). An isolate was graded ESBL producer
when its zone of inhibition varied by $5 mm among at least one
of the combination disks and its coordinate comprising of standard
antibiotic disk. E. coli ATCC 25922 was used as a negative control
while K. pneumoniae ssp. pneumoniae ATCC 700603 served as positive
control [18,19].
Phenotypic assays to determine virulence factors
a) Alpha-hemolysin production. The detection of alpha-
hemolysin was performed by analysing the hemolytic zone observed
after overnight growth at 37uC on sheep blood (5%) agar [20].
b) Haemagglutination. A suspension of human A +ve blood
and PBS was mixed on a VDRL (venereal diseases research
laboratory - test) cavity slide with a single colony of E. coli. After
incubation on rotor at room temperature for some minutes,
agglutination was seen. Similarly, haemagglutination was carried
out in the presence of D-mannose. An ATCC E. coli 25922 strain
was used as a negative control for mannose sensitive
haemagglutination assay and a known strain of E. coli repeatedly
giving positive was taken as control for the assay [21].
c) Cell Surface Hydrophobicity. Bacteria were tested for
their hydrophobic property by using different molar
concentrations of ammonium sulphate in VDRL tile; 40 mlo f
bacterial suspension in PBS was added in each of the wells
containing 1 M, 1.4 M and 2 M ammonium sulphate. Clumps
were seen by naked eyes. Strains were considered hydrophobic, if
they aggregated in the PBS concentration of #1.4 M [21].
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Hank’s balanced salt solution to get appropriate dilutions and
mixed with human serum in a sterile tube and incubated in a
water bath at 37uC and inoculated on nutrient agar plates at 0 hr,
1 hr, 2 hr of incubation in water bath. Growth at 0 hr was taken
as control. E. coli was considered sensitive if count dropped to 1%
and was considered resistant if .90% of the organisms survived
after 2 hrs of incubation. An E. coli isolate that was consistently
serum resistant and a one which was consistently sensitive were
used as positive and negative controls respectively [22].
Serotyping
Typing of somatic antigens was performed at the National
Salmonella and Escherichia Centre, Central Research Institute,
Kasauli, India, using antisera against O antigens - O1 to O173.
O25 positive E. coli strains were further subjected to genotyping by
a recent method based on allele-specific PCR targeting the
rfbO25b subgroup gene locus [23].
Repetive extragenic palindromic PCR
DNA sequences of primers used for Rep - fingerprinting were as
follows: Forward Rep2a2: 59-ACGGCTTATCGGGCCTA-39,
Reverse Rep1Ra1:59-GCGACGGCATCAGGC-39. PCR ampli-
fication was carried out in 20 ml reaction mixture consisting of
106 Taq buffer, 25 mM MgCl2, 10 mM dNTP, 100% DMSO,
100 pM of each primer and 2 U of Taq DNA polymerase and
5 ml of template. The PCR conditions were 95uC for 7 min,
followed by 30 cycles of DNA amplification consisting of 45 s at
95uC, 1 min at 40uC and 8 min at 65uC followed by 16 min
incubation at 65uC. The amplicons were run on 1.5% agarose gels
and were analyzed by BionumericsH software [24,25].
Detection of O25b subgroup strain by PCR
The newly described O25b O type E. coli were detected by using
the following primers gndbis.f (59ATACCGACGACGCC-
GATCTG-39) and rfbO25b.r (59TGCTATTCATTATGCG-
CAGC-39). Annealing temperature of 60uC was used to generate
a PCR product of 300 bp with the conditions as previously
described [23].
Statistical Analysis
Chi square test was used to compare the occurrence of virulence
markers in cases and controls. P values less than 0.05 was
considered significant.
Results and Discussion
Incidence of UTI in relationship with gender and
socioeconomic status
In this study we observed a higher proportion of UTI in females
(64%) than in males (36%). This is understandable due to the
anatomy and is a consistent trend worldwide. Peak in the
incidence of UTI was observed in the age groups 11–21 and
60–71 years. Among these, elderly patients are likely predisposed
to conditions such as urinary tract obstruction, poor bladder
emptying, and diabetes mellitus, etc. These factors favor
colonization of bacteria and play an important role in UTI.
Other studies have also reported similar findings [26,27]. India has
a large infection burden and the genito-urinary infections are very
prominent. This may be due to a less affordable personal/
community hygiene for some of the economically backword
populations. We targeted these groups and analyzed strains
obtained from such communities who reported for the UTI in
periurban Pune. As such there is not much information available
from India on the genetic and phenotypic diversity of UPEC. This
information should therefore be construed as the first systematic
analysis performed on a diverse type of patients/samples.
Virulence characteristics of UPEC from India
a) Type 1 (MSHA) and P fimbriae (MRHA). In the present
study, 45% of the UTI isolates and 25% of fecal isolates showed
the presence of type 1 (Mannose sensitive hemagglutination -
MSHA) fimbriae. Thus the difference among UTI and fecal
isolates was not statistically significant. It was found that 40% of
UTI isolates and 8% of E. coli isolates from the controls exhibited
P fimbriae (Mannose resistant hemagglutination -MRHA). The
difference was statistically significant (P=0.0002). Expression of
type 1 fimbriae was more discerned in isolates from the cases of
simple UTI and cystitis. In our observation, maximum P fimbriae
positive isolates were highly associated with simple UTI, while
only 10% of such isolates caused pyelonephritis. As such there is
no relation among the occurrence or severity of symptoms/the site
of infection and fimbrial expression (of P or type1) in case of
bacterial isolates from urine [28].
Our observation was in agreement with another study [29],
wherein the presence of type 1 fimbriae was seen in 71% of isolates
of E. coli from UTI and in 60% of isolates of E. coli from the
control fecal flora. Taken together, UTI associated isolates did not
show any significant expression of MSHA compared to controls;
however, Najar et al. (2007) [29] showed an overall higher
expression of type 1 fimbriae in both the UTI isolates and controls.
Many studies have demonstrated the presence of P fimbriae as
maximum in UTI isolates than in fecal isolates of healthy persons
[29,30].
Although, since we looked only at phenotypes of the isolates in
vitro, it is difficult to dwell upon the real significance of the fimbrial
expression patterns vis a vis the niche tropism (upper or lower UTI)
and its impact on different outcomes of infection – these are
largely the phenomena due to microbial mechanisms operating in
vivo. Normally, the expression of P fimbriae is increased among
isolates associated with lower urinary tract infections, basically
resembling an ‘in vivo’ situation as there is an interplay between
type1-fimbriae and P-fimbriae expression (‘‘switch-off’’ of Type 1
fimbriae leads to increased motility of bacteria and finally to
binding of P-fimbrial adhesin to receptors on kidney epithelial
cells). The higher or lower expression itself might therefore only
give an idea about the quantitative occurrence of P fimbriae, but
not about the different adhesion subunits which would be more
relevant with respect to upper/lower UTI infections.
b) Hemolysin. Production of alpha hemolysin was observed
in 60% of UPEC from the cases while only 2% of E. coli isolates
from feces produced alpha hemolysin (P=0.0001). Other studies
have also reported similar findings [31]. In our observation,
hemolysin was highest in pyelonephritis, lower in cystitis and least
in asymptomatic bacteriuria.
c) Serum resistance and cell surface hydrophobicity.
Serum resistance and cell surface hydrophobicity markers were
not significantly present in E. coli isolates from patients compared
to control fecal isolates: 55% and 76% of urinary E. coli isolates
showed serum resistance and cell surface hydrophobicity
respectively and the control isolates showed 40% and 70% for
serum resistance and cell surface hydrophobicity respectively.
The difference in both the cases was not statistically significant
(p=0.16/p=0.51). This trend has been reported earlier and our
study confirmed the same for Indian isolates [32].
Occurrence of virulence factors in UPEC strains confirms the
association of UPEC with urinary pathogenicity. It was interesting
Profiling Multi-Resistant UPEC from Western India
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prevalent in patient groups than in controls (Table 1). Such a
significant difference was noticed earlier, indicating that several
virulence factors act synergistically to cause infection of the urinary
tract [33]. Nevertheless, it was interesting that 8% of the isolates
(12/150) from infection cases did not reveal any virulence markers
under investigation. These were the isolates from complicated
UTI. It appears that these isolates, though devoid of any virulence
factors as probed by us, were able to localize in the deeper tissues
of a compromised urinary tract where scarcely any drug reaches in
therapeutic quantum. It may also be due to the reason that they
might possess virulence markers/mechanisms other than those
tested by us.
We screened 19 mucoid UPEC isolates by phenotypic and
biochemical characterization and found that all were from patient
groups and were capsulated. Out of the 19 mucoid UPEC, 11
were capsulated and serum resistant. Capsule confers serum and
phagocyte resistance and this could be attributed to sialic acid
residues that subvert the ability of bacterial surface to activate
complement by alternative pathway thereby augmenting the
virulence potential of such pathogens. However, eight of the
mucoid strains were susceptible to serum, perhaps due to the non
capsular factors and this might have a role in serum resistance.
Antimicrobial susceptibility profiles of UPEC
Antimicrobial susceptibility testing was carried out on all the
clinical isolates. The majority of isolates were sensitive to
nitrofurantoin - 86 (57.3%) followed by ciprofloxacin - 78 (52%)
and nalidixic acid - 74 (49%). This study showed high resistance to
amoxicillin - 101 (67.3%), tetracycline - 92 (61.3%), and
cefotaxime - 68 (45.3%) (Figure 1). Upon testing for ESBL, we
found that 32 (21.3%) were ESBL producers. A high proportion
(31.3%) of these ESBL-producing isolates was belonging to the
serotype O25. Four of these were positively tested for the subgroup
O25b (Figure 2), which has been linked to a clonally related group
of highly virulent, multiresistant E. coli strains (B2-O25b-ST131-
CTX-M-15) that are emerging among humans and animals
worldwide [34,35]. Further studies, i.e. multi locus sequence
typing (MLST), macrorestriction analysis, and determination of
beta-lactamase enzymes are needed to unravel the phylogenetic
Table 1. Occurrence of virulence phenotypes in E. coli isolates from cases and controls.
Virulence phenotypes
Number of isolates from cases (%) total
cases=150
Number of isolates from controls (%) total
controls=50 P-value
MRHA 60 (40.0) 4 (8.0) 0.0002
MSHA 68 (45.3) 12 (24.0) 0.406
Hemolysin 90 (60.0) 1 (2.0) 0.00001
SR 83 (55.3) 20 (40.0) 0.16
CSH 120 (80.0) 35 (70.0) 0.51
doi:10.1371/journal.pone.0018063.t001
Figure 1. The antimicrobial susceptibility and resistance pattern of 150 UTI isolates from India. Nitrofurantoin was consistently the most
active (59%) of the systemically active antimicrobials, with ceftazidime, giving similar results (54.7%). These were followed by ciprofloxacin (52%),
nalidixic acid (49%) and gentamicin (48%), but sensitivity to amoxicillin was found to be low (32.7%). Sensivity profiles of Co-trimoxazole (36.7%) and
tetracycline (38.7%) were quite similar.
doi:10.1371/journal.pone.0018063.g001
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worldwide recognized clonal groups and to characterize the
remaining multiresistant isolates observed. ESBL isolates were
frequently (65.6%) associated with a hemolytic phenotype, with a
higher rate than the non-ESBL-producing UPEC strains (58.5%).
Hence, although it is a commonly accepted fact that bacterial
pathogens acquire resistance determinants and express a multire-
sistant phenotype at the cost of their virulence properties, the
frequent observation of hemolytic UPEC among our strain
collection underlines the possible emergence of highly virulent
multiresistant strains [36] in this area.
It is particularly worrisome that more than half of the ESBL
producers (53.1%) in our collection were resistant to ciprofloxacin
suggesting that they may be resistant to all available fluoroquino-
lones - the drug of choice for treatment of infections caused by
ESBL-producing strains. Overall, nitrofurantoin and ciprofloxacin
were found superior to amoxicillin and co-trimoxazole. None of the
uropathogens from this study area were 100% susceptible to any of
the antimicrobial substances used. Prior studies have shown a
sensitivity rate of 95–100% to nitrofurantoin [37]. But in our study,
nitrofurantoin showed only 57.3% sensitivity; the reason for this low
sensitivity and high resistance to almost all antimicrobials in the
study area may indicate difference in antimicrobial usage, infection
control practices and other unrecognized factors including genetic
propensity of these strains to accumulate mutations conferring
MDR phenotypes. Periodic review and formulation of antibiotic
policy are needed to control acquisition of drug resistance. Further
studies for better understanding of the interaction of different
virulencefactorsatmolecularlevelarenecessaryasmosturovirulent
strains express multiple virulence factors simultaneously. We believe
that the methods of detection of the above mentioned virulence
markers are reasonably easy and screening them in a clinical
microbiology laboratory is a worthwhile exercise.
Figure 2. PCR based detection of O25b subgroup that is linked
to the B2-O25b-ST131-CTX-M-15 clonal group of strains.
Among 32 ESBL producers in our collection (n=150) four were positive
for O25b subgroup (Lanes 1 to 4); lane 5, positive (strain showing
consistently positive); lane 6, negative; M, 100 bp DNA ladder.
doi:10.1371/journal.pone.0018063.g002
Table 2. Distribution of various O-antigens in clinical isolates of E. coli.
O-Antigen Pyelonephritis Prostatitis Cystitis Simple UTI Septicaemia PUO Total
O 1 - 1 - 52- 8
O2 - 1 - 1 - - 2
O 9 - - - --- 0
O14 1 - - - - - 1
O20 1 - - - 1 1 3
O25 6 7 11 15 2 4 45
O44 1 - - 2 1 - 4
O45 - - 1 - - - 1
O60 1 1 4 1 - 7
O64 - - 1 1 - - 2
O76 - - 1 3 - - 4
O79 - 1 - - - - 1
O84 - - - 1 - - 1
O102 3 1 - 8 - 1 13
O116 - - - 1 - - 0
O120 2 2 3 6 - 1 14
O130 - 1 - 1 - - 2
Rough 1 1 2 2 - 6
O 9 5 1 - - --- 1
O100 - - - 1 - - 1
Non- viable - 1 - - 1
Non E. coli -1 1 2 - 1 5
Untypeable 5 - 3 13 3 4 28
Total 22 15 24 65 12 12 150
doi:10.1371/journal.pone.0018063.t002
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In our study, as many as 19 different serotypes (O1, O2, O9,
O14, O20, O25, O44, O45, O60, O64, O76, O79, O84, O102,
O116, O120, O130, O95, O100) were observed among the
cultured UPEC. Out of these, 27 E. coli were untypeable; six
expressed a rough O antigen and five were Escherichia species (non-
E. coli; NEC). A majority of E. coli isolates expressed O antigens -
O25 (31.9%), O102 (9.7%), O120 (8.3%), and O1 (5.6%).
Serotype O25 was predominantly found to be isolated from
patients with pyelonephritis, prostatitis, cystitis and simple UTI.
Renal failure associated isolates mainly belonged to O25 and
O102 serotypes (Table 2).
To determine the relatedness of the strains, a dendrogram based
on rep-PCR based fingerprint data was constructed in Bionumer-
icsH. For this study, the clinical strains from India and 50 German
isolates were used while the fecal isolates were excluded as the aim
of this experiment was not to prove pathogenicity of the ExPEC
but to see how diverse and clonal they are and to analyze Indian
isolates in juxtaposition with German strains. Apart from the
occurrence of singleton strains, the dendrogram obtained could be
broadly classified into 5 major clusters: Indian-German cluster I
(n=15 strains), Indian cluster I (n=63), mixed cluster I (n=17)
and mixed clusters IIa/IIb (n=30), which include strains from all
the three locales, as depicted in Figure 3. All the strains that
clustered under Indian branch (exceptionally harboring one isolate
from Germany) revealed very diverse pattern, except for a few
ones - it appears that the bacteria we cultured were very diverse
and the ones which were close in the cluster have no phenotypic
resemblances with each other in terms of antimicrobial resistance
profile or serotype or other virulence markers. This may be due to
the reason that the UPEC in this study area could be highly
diverse at sub-species and serotype levels.
The mixed cluster I contained a group of 17 bacterial isolates
from India, Germany and from global sources. This cluster
predominantly comprises of APEC from cases of septicemia in
chicken or goose, while the remaining seven strains were human
UPEC, including strain CFT073, or they were septicemia-
associated strains (SEPEC). The mixed cluster II was subdivided
into two subclusters- subcluster IIa (n=10) and subcluster IIb
(n=20). The subcluster IIa largely encompasses APEC. Eight out
of ten members of this cluster were APEC and the rest were UTI
pathogens from humans. In the subcluster IIb, human isolates as
well as isolates from animals were grouped together. There was no
discrete band pattern between strains isolated from different
sources; out of twenty strains in subcluster IIb nine were APEC,
seven were UPEC of humans and two from dog, one was a human
SEPEC and finally the archetypical NMEC strain RS218
grouping within this subcluster. From this analysis, we may
conclude that the technique of rep-PCR is not resolving enough to
distinguishing strains that portray similar phenotypic markers;
nevertheless the Indian ExPEC population was clearly distin-
guishable from German ExPEC. We also found that the isolates
from different animal sources were more or less grouping into
distinct clusters, indicating that this technique can also be used to
find the sources of infection in a reservoir such as a water body.
In conclusion, our observations form an important baseline
data-set towards understanding the virulence properties, antibiotic
resistance profiles and genetic diversity of UPEC from India. We
hope that such observations will be more meaningful towards
systematically unraveling the population genetic structure of
UPEC and their propensity to spread, or emerge with multi drug
resistance phenotypes in new epidemiological territories. In the
backdrop of this work, future studies involving decipherment of
MDR mechanisms, lineage tracking based on MLST [16] and
whole genome sequencing of representative isolates from different
MLST clades [2] shall be imminent. Further, the ‘omics’ inspired
studies will ultimately help understanding of the functional
Figure 3. Dendrogram based on rep-PCR, developed in
BionumericsH revealed genetic relationships of E. coli repre-
senting Indian clinical isolates and ExPECs from global
sources. Different geographic clusters are labeled. Upper scale denotes
genetic distance.
doi:10.1371/journal.pone.0018063.g003
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greater details. On the clinical side, it will be possible to ascertain
reservoirs of infection which could be important in understanding
the mechanisms of chronic and recurrent UTI [38] in a
community setting and how they are maintained within or in
the vicinity of different human populations of a multicultural and
densely populated country such as India.
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